Implantable Defibrillator Therapy: A Clinical Guide

Antonio Pacifico,Philip D. Henry,Gust H. Bardy,Martin Borggrefe,Francis E. Marchlinski, MD, FACC, FHRS

Implantable Defibrillator Therapy: A Clinical Guide
Format
Paperback
Publisher
Springer-Verlag New York Inc.
Country
United States
Published
5 November 2012
Pages
410
ISBN
9781461353720

Implantable Defibrillator Therapy: A Clinical Guide

Antonio Pacifico,Philip D. Henry,Gust H. Bardy,Martin Borggrefe,Francis E. Marchlinski, MD, FACC, FHRS

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original AID device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the more sinusoidal waveform of ventricular fibrillation.
The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by Arrhythmia Management Devices were designed to reduce the arrhytlunia burden and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.

This item is not currently in-stock. It can be ordered online and is expected to ship in 7-14 days

Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.

Sign in or become a Readings Member to add this title to a wishlist.